Daily Market Briefing

2026-09-23 · Money Checkup market briefing

# Broad Declines Across Indices as Biotech and Consumer Stocks Sink

The market pulled back today, with all three major indices closing in the red and the smaller-cap Russell 2000 leading losses. The Nasdaq Composite fell 1.13%, the S&P 500 dropped 0.75%, and the Dow Jones retreated 0.68%, while the Russell 2000 shed 1.77%—suggesting weakness was especially pronounced in smaller, riskier names.

The day's biggest story came from the losers' list, where biotech and healthcare names took a beating. Jaguar Health plunged 74.1%, while Cullinan Therapeutics sank 22.2% and Rapport Therapeutics fell 17.7%. Beyond pharma, consumer-facing sectors also struggled: restaurants as a whole dropped 16.1% (affecting McDonald's, Starbucks, and Chipotle among the 28 companies tracked), and rental/leasing companies fell 16.2%. Tobacco also cratered, down 27.5, led by Turning Point Brands. These broad declines across consumer discretionary and commodity-adjacent sectors suggest investors may be bracing for tighter economic conditions or shifting spending patterns.

On the flip side, technology and industrial plays found pockets of strength. 8X8 Inc. surged 15.1%, Fastly gained 13.7%, and ACM Research was up 6.4%, while Methode Electronics and Vicor Corp. also posted solid gains in the 5-10% range. Electronics Distribution as a sector led all industries with a +34.1% return, though that figure reflects just one company (GameStop Corp.). More broadly, Computer Software & Peripheral Equipment retail climbed 10.3% across six companies including Hewlett Packard Enterprise and TD Synnex, and Integrated Oil Companies rose 9.5% with eight members gaining, including Chevron and ConocoPhillips.

Recent 10-K filings added context on fundamental health. Airway Inc. filed with a Health Score of 79.7, suggesting solid operational standing, while others painted a murkier picture: Nutanix came in at 37.0, United Natural Foods at 42.8, and American Battery Technology at just 22.7. More concerning, five companies are currently flagged with going-concern audit notes—Entrada Therapeutics, FS KKR Capital, Bain Capital Specialty Finance, New Mountain Finance, and Innovative Industrial Properties—indicating auditors have substantial doubt about their ability to continue operating. These flags warrant close attention from any investor holding or considering positions in this group.

The day's moves reflect a classic risk-off rotation: out of healthcare, consumer discretionary, and high-multiple tech, into energy, industrials, and software infrastructure plays. Whether this represents a temporary pullback or a broader repricing remains an open question, but the concentration of losses in smaller-cap and consumer-oriented names suggests investors are being more selective about where they put capital. For those using value and quality screens, today's data underscores the importance of checking recent filings and audit flags before adding positions.